Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Inter-Segment Elimination		-110.08M
Fast Selling Drinks		96.77M
Advertising Agency		51.32M
Health Business		232.25M
Total		270.26M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
North China		3.40M					-	-	-	-
Central China		2.84M					-	-	-	-
East China		91.83M					-	-	-	-
South China		6.51M					-	-	-	-
Hong Kong, Macao and Taiwan		1.38M					-	-	-	-
Northwest		93.47M					-	-	-	-
Southwest		62.90M					-	-	-	-
Northeast		2.35M					-	-	-	-
China		-					233.75M	333.02M	471.12M	708.13M
China Growth		-					-29.81%	-29.31%	-33.47%	-49.48%
Total		264.68M					233.75M	333.02M	471.12M	708.13M
Total Growth		-					-29.81%	-29.31%	-33.47%	-49.48%

Source: S&P Global Market Intelligence.